CT assessment of the effect of fluticasone propionate aqueous nasal spray treatment on lower turbinate hypertrophy due to vasomotor rhinitis

Acta Oto-Laryngologica

Volumn 126, Issue 1, 2006, Pages 37-42

  Arikan, Osman Kursat ^a   Koc, Can ^a   Kendi, Tuba ^a   Muluk, Nuray Bayar ^a   Ekici, Aydanur ^a  

^a KIRIKKALE UNIVERSITY   (Turkey)

Author keywords

CT; Fluticasone propionate; Lower turbinate hypertrophy; Vasomotor rhinitis

Indexed keywords

FLUTICASONE PROPIONATE; PLACEBO;

AEROSOL; ARTICLE; BONE DEFECT; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; HUMAN; HYPERTROPHY; LOWER TURBINATE HYPERTROPHY; NOSE MUCOSA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; VASOMOTOR RHINITIS; VISUAL ANALOG SCALE;

ADMINISTRATION, INTRANASAL; ADULT; ANDROSTADIENES; ANTI-INFLAMMATORY AGENTS; CHRONIC DISEASE; ENDOSCOPY; FEMALE; HUMANS; HYPERTROPHY; MALE; NASAL OBSTRUCTION; PHYSICAL EXAMINATION; PROSPECTIVE STUDIES; QUESTIONNAIRES; RHINITIS, VASOMOTOR; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TURBINATES;

EID: 28844493687     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016480510012219     Document Type: Article

References (23)

1. Rakover Y, Rosen GA. Comparison of partial lower turbinectomy and cryosurgery for hypertrophic lower turbinates. J Laryngol Otol 1996;110:732-5.
2. Elwany S, Harrison R. Inferior turbinectomy: comparison of four techniques. J Laryngol Otol 1990;104:206-9.
3. Passali D, Lauriello M, Anselmi M, Bellusi L. Treatment of hypertrophy of the lower turbinate: long-term results in 382 patients randomly assigned to therapy. Ann Otol Rhinol Laryngol 1999;108:569-75.
4. Coste A, Yona L, Blumen M, Louis B, Zerah F, Rugina M, et al. Radiofrequency is a safe and effective treatment of turbinate hyerpertrophy. Laryngoscope 2001;111:894-9.
5. Jackson LE, Koch RJ. Controversies in the management of lower turbinate hypertrophy: a comprehensive review. Plast Reconstr Surg 1999;103:300-12.
6. Muluk NB, Oguzturk O, Koc C, Ekici A. Minnesota multiphasic personality inventory profile of patients with allergic rhinitis. J Otolaryngol 2003;32:198-202.
7. Barbee RA, Lebowitz MD, Thompson HC, Burrows B. Immediate skin-test reactivity in a general population sample. Ann Intern Med 1976;84:129-33.
8. Mygind N. Measurement of nasal airway resistance - is it only for article writers? Clin Otolaryngol 1980;5:161-3.
9. Stringer SP, Mancuso AA, Avino AJ. Effect of a topical vasoconstrictor on computed tomography of paranasal sinus disease. Laryngoscope 1993;103:6-9.
10. Clarke LP, Velthuizen RP, Clark M, Gaviria J, Hall L, Goldgof D, et al. MRI measurement of brain tumor response: comparison of visual metric and automatic segmentation. Magn Reson Imaging 1998;16:271-9.
11. Meltzer EO, Rickard KA, Westlund RE, Cook CK. Onset of therapeutic effect of fluticasone propionate aqueous nasal spray. Ann Allergy Asthma Immunol 2001;86:286-91.
12. nd WMA General Assembly. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2000;284:3043-9.
13. Mabry RL. Allergic rhinitis. In: Cummings CW, Fredrickson JM, Harker LA, Krause CJ, Richardson MA, Schuller DE, editors. Otolaryngology head & neck surgery, 3rd ed, vol. II. St. Louis, MO: Mosby-Year Book; 1998. p. 902-9.
14. Holmstrom M. Clinical performance of fluticasone propionate nasal drops. Allergy 1999;54:21-5.
15. Kivisaari E, Backer RC, Price MJ. Comparison of once daily fluticasone propionate aqueous nasal spray with once daily budesonide reservoir powder device in patients with perennial rhinitis. Clin Exp Allergy 2001;31:855-63.
16. Pipkorn U, Berge T. Long-term treatment with budesonide in vasomotor rhinitis. Acta Otolaryngol (Stockh) 1983;95:167-71.
17. Fairbanks DNF, Kaliner M. Nonallergic rhinitis. In: Cummings CW, Fredrickson JM, Harker LA, Krause CJ, Richardson MA, Schuller DE, editors. Otolaryngology head & neck surgery, 3rd ed, vol. II. St. Louis, MO: Mosby-Year Book; 1998. p. 910-20.
18. Ciprandi G. Treatment of nonallergic perennial rhinitis. Allergy 2004;76:16-22; discussion 22-3.
19. Banov CH, Lieberman P. Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis. Ann Allergy Asthma Immunol 2001;86:28-35.
20. Lieberman PL, Settipane RA. Azelastine nasal spray: a review of pharmacology and clinical efficacy in allergic and nonallergic rhinitis. Allergy Asthma Proc 2003;24:95-105.
21. Storms WW. Risk-benefit assessment of fluticasone propionate in the treatment of asthma and allergic rhinitis. J Asthma 1998;35:313-36.
22. Bryson HM, Faulds D. Intranasal fluticasone propionate: a review of its pharmocodynamic and pharmacokinetic properties, and therapeutic potential in allergic rhinitis. Drugs 1992;43:760-75.
23. Van As A, Bronsky E, Grossman J, Meltzer E, Ratner P, Reed C. Dose tolerance study of fluticasone propionate aqueous nasal spray in patients with seasonal allergic rhinitis. Ann Allergy 1991;67:156-62.